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Abstract 
Late life involves a variety of different challenges to well-being. This study extends upon and 
qualifies propositions drawn from the paradox of well-being in aging using 15-year longitudinal 
data on depressive symptoms from old and very old participants in the Australian Longitudinal 
Study of Ageing (at baseline n = 2,087, M age = 78.69 years, range = 65-103 years; 49.40% 
women). We first examined age-related trajectories in depressive symptoms from young-old to 
oldest-old, taking into account (changes in) relevant correlates, pathology, and mortality, and, 
second, investigated gender differences in these trajectories. Results revealed that age-related 
trajectories of depressive symptoms were indeed predictive of mortality hazards. The unique 
predictive effects of both level of, and change in, depressive symptoms were independent of one 
another and hold after taking into account education as well as changes in marital status, living 
arrangements, cognitive function, and illness burden. In addition, results indicated that 
depressive symptoms were elevated among participants suffering from arthritis, and increased 
with age more markedly in men than in women. In particular, the significant age by gender 
interaction indicated that the gender gap in depressive symptoms reduced from young-old to old-
old and reversed in very old age when men showed more depressive symptoms than women. 
Qualifying the paradox of well-being in aging, findings demonstrate that depressive symptoms 
increased from young-old to oldest-old and suggest that age-, pathology-, and mortality-related 
changes should be examined in concert to advance our understanding of individual differences in 
depressive symptom trajectories in late life. (Word count: 248) 
Keywords: aging, depressive symptoms, mortality, arthritis, joint longitudinal-survival model
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Trajectories of Depressive Symptoms in Old Age: Integrating Age-, Pathology-, and Mortality-
Related Changes 
Late life involves many challenges with consequences for changes in well-being (Baltes, 
1997; Berg, 1996; Birren & Cunningham, 1985). Yet, in contrast to age-normative declines in 
physical health and cognitive functioning, a myriad of studies provide empirical evidence of a 
relative stability or even improvement in well-being in old age (Charles & Carstensen, 2010; 
Charles, Reynolds, & Gatz, 2001; Mather, 2012; Mroczek & Kolarz, 1998). This preservation of 
well-being despite age-related losses has been coined “the stability paradox of well-being in 
aging” (Kunzmann, Little, & Smith, 2000; Mather, 2012). From our perspective, however, the 
empirical evidence for the paradox has three important limitations. First, evidence mostly 
concerns age-related changes in the cognitive component of subjective well-being (e.g., life 
satisfaction; Diener, Suh, Lucas, & Smith, 1999; Gana, Bailly, Saada, Joulain, & Alaphilippe, 
2013), whereas results regarding age-related changes in affective components of subjective well-
being are less clear (Schilling, 2006). Second, the well-being paradox may hold only until early 
old age and less is known about life periods for which major loss experiences are frequent such 
as old-old and oldest-old age (Baltes & Smith, 2003). Third, a major challenge for research 
examining age-related changes in well-being pertains to the fact that development is shaped by 
the interplay between age-, pathology-, and mortality-related processes (Baltes, Lindenberger, & 
Staudinger, 2006). Ignoring pathology- and mortality-related processes can lead to biased 
estimates in age-related changes, such that depressive symptoms in very old age are likely 
underestimated because of selective attrition due to pathology and mortality (Mirowsky & 
Reynolds, 2000). For instance, findings from the Veterans Affairs Normative Aging Study 
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revealed that men who died within one year after assessment showed a faster rate of decline in 
life satisfaction than men who survived (Mroczek & Spiro III, 2005).  
In the present study, we therefore focused on examining age-related trajectories of 
depressive symptoms, an affective component of subjective well-being, across an age spectrum 
ranging from young-old (65-75 years) to the oldest-old (85 years and above; Baltes & Smith, 
2003; Neugarten, 1996). We made use of longitudinal information about depressive symptoms 
from 2,087 older adults who participated for up to 15 years (1992-2007) in the Australian 
Longitudinal Study of Ageing (ALSA; Luszcz et al., 2014). Instead of taking conventional 
approaches, such as multilevel modeling, that assume dropouts are missing at random, we argue 
that a joint modeling of age-related trajectories and survival data offers a fruitful avenue to 
extend past research toward a better understanding of age-related changes in depressive 
symptoms and their associations with pathology and mortality in old age (Graham, Ryan, & 
Luszcz, 2011; Zhang, Kahana, Kahana, Hu, & Pozuelo, 2009). Our objectives therefore were 
two-fold. First, we examined the pattern of age-related changes in depressive symptoms from 
young-old to oldest-old, taking into account (changes in) relevant correlates of well-being, 
pathology, and mortality (Alberta Health, 2003; Murray et al., 2012) that are known risk factors 
for impaired well-being. Second, considering gender differences in the level of, and age-related 
changes in, depressive symptoms (Barefoot, Mortensen, Helms, Avlund, & Schroll, 2001), we 
examined how findings regarding the so-called paradox of well-being may differ between men 
and women. 
Paradox of Well-Being 
Developmental change involves both growth in, and losses of, functional capacity, with 
the proportion of losses increasing and that of gains decreasing with aging (Baltes et al., 2006). 
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Frequently referred to as the gain-loss dynamic, this increasingly negative general pattern with 
advancing age, the myriad of empirical reports attesting to the average stability of well-being 
into old age are surprising (Carstensen et al., 2011; Charles et al., 2001). For example, life 
satisfaction increased over an 8-year period in a sample of older adults (n = 899, M age = 72.73 
years, age range = 62-95 years), controlling for covariates such as gender, education, and self-
perceived health (Gana et al., 2013). In addition, positive affect remained stable from young to 
middle-age (n = 2,804, age range = 15-90 years at baseline) and showed only modest decline into 
old age. Furthermore, negative affect decreased over a 23-year period (Charles et al., 2001). This 
maintenance of well-being despite age-related losses has been coined “the stability paradox of 
well-being in aging” (Kunzmann et al., 2000; Mather, 2012).   
Changes in Depressive Symptoms as Related to Age, Pathology, and Mortality 
It is increasingly recognized that changes in depressive symptoms and other aspects of 
well-being may be due to age-, pathology- and/or mortality-driven changes (Baltes & Smith, 
2003; Fauth, Gerstorf, Ram, & Malmberg, 2014; for an overview, see Gerstorf & Ram, 2013; 
Infurna, Gerstorf, & Ram, 2013; Schilling, Wahl, & Reidick, 2013; Zhang et al., 2009). In the 
following, we review the literature on the role of these three dimensions of changes in depressive 
symptoms.  
The role of age. Evidence suggests that depressive symptoms increase in old age (Zarit, 
Femia, Gatz, & Johansson, 1999). However, findings regarding the age-related trajectory of 
depressive symptoms in old age remain inconclusive in part due to differences in sample 
composition. Few studies have used samples covering the entire older adulthood period, 
spanning from young-old to oldest-old (For exceptions, see Byers et al., 2012; Clarke, Marshall, 
House, & Lantz, 2011). For example, during a 20-year period, 20% of a sample of community-
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dwelling women 65 years or older (n = 7,240 at baseline) actually showed persistently high or 
increasing depressive symptoms (Byers et al., 2012). The variation in patterns of age-related 
changes, may suggest that some older adults may be more protected against depression due to 
socio-emotional selectivity and wisdom (Blazer & Hybels, 2005). Others may be more at risk 
due to limitations in these and other attributes. Thus, claims of age-related changes in depressive 
symptoms need to take into account the (changes in) adversities and protective factors in old age 
(Blazer & Hybels, 2005).  
 The role of pathology.   The association between age and depressive symptoms, often 
arises in the context of age-related changes in chronic health conditions and disability 
(Alexopoulos, 2005; Blazer, 2003). Instead of life-threatening health conditions, the present 
study focused on arthritis, the most common chronic health condition (Australian Institute of 
Health and Welfare, 2014; Hootman, Helmick, & Brady, 2012).  
Arthritis is diagnosed in 14.8% of the Australian population (Australian Institute of 
Health and Welfare, 2014). The prevalence of arthritis increases with age and is highest among 
those aged 75 years or above, with about half of this cohort in Australia having arthritis 
(Australian Government, 2010). Similarly, in the Australian Longitudinal Study of Ageing, 54% 
of the sample of 2,087 individuals over the age of 65 years reported having arthritis (Caughey et 
al., 2010). In addition, individuals with arthritis rated their pain as the most severe, among 22 
chronic health conditions including back pain, migraine, and heart disease (Alberta Health, 2003). 
Past research has shown that a higher intensity of chronic pain is associated with a higher level 
of depressive symptoms and a higher level of negative affect in everyday life (Tennen, Affleck, 
& Zautra, 2006; Zautra, Smith, Affleck, & Tennen, 2001).  Using a sample of individuals living 
with arthritis for an average of 10 years (n  = 423, M age = 44.5 years, 88% women), Sirois and 
Depressive Symptoms, Pathology, and Mortality 7 
Hirsch (2013) reported pain severity to be positively associated with depressive symptoms at 
baseline. In the six-months follow-up, pain severity was associated with depressive symptoms, 
controlling for depressive symptoms at baseline (Sirois & Hirsch, 2013). In addition, among 
married individuals with rheumatoid arthritis (RA), both baseline and one-year changes in RA 
symptoms including pain, were associated with depressive symptoms in the spouse (Lam, 
Lehman, Puterman, & DeLongis, 2009). These results suggest that although chronic conditions 
such as arthritis are not life threatening (Caughey et al., 2010), individuals with arthritis 
experience chronic pain that is associated with losses in emotional well-being (Marks, 2013) and 
may also have consequences for spouses. 
The role of impending mortality.  For mortality-related processes, findings from a 
meta-analysis have shown that a higher level of depressive symptoms in old age is associated 
with a higher risk of mortality (Saz & Dewey, 2001). For example, depressive symptoms 
predicted mortality over a five-year period in a sample of community-dwelling older adults, M 
age = 76.2 years (St John & Montgomery, 2009). Likewise it has been shown that change in 
depression status (i.e. never depressed, incident depression, remitted depression, and chronic 
depression; measured using the recommended CES-D cutoff of 16; Radloff, 1977) over a period 
of two years was associated with mortality in the subsequent six years (Anstey & Luszcz, 2002). 
Compared to the never depressed group, the incident depression and chronic depression groups 
had a higher risk of mortality but the remitted depression group did not. The association between 
depressive symptoms and mortality, however, may depend on the length of the follow-up period. 
In general, the strength of the association between depressive symptoms and mortality tends to 
be smaller with longer follow-up periods (Saz & Dewey, 2001), during which other factors may 
be more consequential.  
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Integrating Age-, Pathology-, and Mortality-Related Changes 
Lifespan psychological theories and empirical findings demonstrate that age-, pathology-, 
and mortality-related processes conjointly shape aging trajectories across domains of functioning 
(Aldwin & Gilmer, 2013; Baltes et al., 2006). For instance, one way to better understand the 
associations between depressive symptoms and mortality in old age is to concurrently track 
longitudinal changes in depressive symptoms and their association with mortality (Zhang et al., 
2009). However, conventional methods of longitudinal data analysis assume dropouts to be 
missing at random (Graham et al., 2011; Rizopoulos, 2012), which may lead to biased estimates, 
such as underestimation of depressive symptoms in advanced age (Mirowsky & Reynolds, 2000). 
Recent developments in longitudinal statistical methodology such as joint modeling have been  
shown to be effective tools for handling the challenge of modeling longitudinal changes with 
dropouts due to mortality (Graham et al., 2011; Rizopoulos, 2012). The basic rationale of joint 
modeling is to simultaneously model the longitudinal data and the survival data, i.e. joining the 
multilevel model and survival model (Rizopoulos, 2012). For example, joint modeling has been 
fruitfully applied in the examination of the association between longitudinal changes in cognitive 
functioning and mortality (Ghisletta, 2008; Ghisletta, McArdle, & Lindenberger, 2006; Graham 
et al., 2011).  
Recently, joint modeling has been applied to data from the Florida Retirement Study. 
Results indicate that an increase in depressive symptoms over 11 years was associated with 
higher mortality rates in older adults (Zhang et al., 2009). Specifically, using time-in-study as the 
time metric, an annual increase of one point in depressive symptoms was associated with a 1.57-
fold increase in mortality, controlling for baseline covariates including age, gender, education, 
marital status, living arrangement, cognitive functioning, and illness burden. Interestingly, the 
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baseline level of depressive symptoms was not associated with mortality. These findings point to 
the importance of examining between-person differences in individuals’ trajectories of 
depressive symptoms to further our understanding of the link between age, mortality, and 
depressive symptoms (Byers et al., 2012; Schilling et al., 2013; Zhang et al., 2009).  
Gender, Depressive Symptoms, and Mortality 
 Gender difference is an important between-person difference in individuals’ trajectories 
of depressive symptoms (Barefoot et al., 2001; Mirowsky, 1996) and mortality (Franceschi et al., 
2000). For example, Franceschi et al. (2000) reported lower mortality risk in women than men 
across all age groups, reflecting differences in their genetic makeup and lifestyle choices that 
have implications for longevity. Hence the gender gap in depressive symptoms may be expected 
to vary with age because of gender differences in the exposure to risk factors (Mirowsky, 1996). 
For example, women tend to experience more chronic health conditions, such as arthritis, and are 
more likely to be widowed in old age, which may predispose them to more depressive symptoms, 
thus widening the gender gap with increasing age. Previous studies showed conflicting results 
with regard to gender differences in how depressive symptoms may change with age. Using 
cross-sectional data from three US samples, findings showed that depressive symptoms 
decreased in successive age groups from young adulthood to early old age and increased from 
early old age to oldest-old for both men and women, with an increasing gender gap from young 
adulthood to oldest-old age (Mirowsky, 1996). Specifically, from young adulthood to early old 
age, the decrease in depressive symptoms across age groups was steeper in men than in women. 
From early old age onwards, the increase in depressive symptoms across age groups was steeper 
in women than in men, resulting in a wider gender gap across the entire period of adulthood such 
that women showed increasingly more depressive symptoms than men across age groups. In 
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contrast, using longitudinal data from Denmark, findings revealed a decreasing gender difference 
in depressive symptoms between age 60 to 80 (Barefoot et al., 2001). Specifically, women 
showed a higher level of depressive symptoms than men from age 60 to 80. However, men 
showed increases in depressive symptoms during the same period but women did not.  
Covariates: Cognitive Functioning and Illness Burden 
 Comorbidity and cognitive functioning may be among the underlying variables that drive 
age-related changes in depressive symptoms and other aspects of health (Gerstorf, Ram, 
Lindenberger, Röcke, & Smith, 2008; Gerstorf, Ram, Lindenberger, & Smith, 2013). In this 
study, we explored whether the associations between the age-related changes in depressive 
symptoms, arthritis diagnosis, and mortality remained after controlling for education, and age-
related changes in living arrangement, marital status, cognitive functioning, and illness burden 
(Anstey, von Sanden, Sargent-Cox, & Luszcz, 2007; Maier & Smith, 1999; Pessin, Rosenfeld, & 
Breitbart, 2002; Rapp, Gerstorf, Helmchen, & Smith, 2008).  
The Current Study 
In this study, we examined associations between age-related changes in depressive 
symptoms, arthritis diagnosis, and mortality, using a large sample from the Australia 
Longitudinal Study of Ageing (ALSA; Luszcz et al., 2014) to corroborate and extend findings 
from the Florida Retirement Study (n = 897; Zhang et al., 2009) in two ways. First, rather than 
using time-in-study, we used chronological age as the time metric (Ghisletta et al., 2006; Graham 
et al., 2011), which allows us to examine whether depressive symptoms increase as individuals 
develop into advanced age. Thus, the use of chronological age instead of time-in-study as the 
time metric allows a more direct operational definition of propositions of the paradox of well-
being. Second, instead of controlling for baseline covariates only as in the Florida Retirement 
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study, our examination of age-related changes in depressive symptoms controlled for the changes 
in covariates including illness burden, cognitive functioning, living arrangement, and marital 
status (for more details see the section “Covariates: Cognitive Functioning and Illness Burden”). 
We expected that depressive symptoms would increase with age and that a higher level of, and 
increases in, depressive symptoms across older adulthood would each be associated with 
increased risks of death, after we had taken into account (changes in) these covariates. 
We examined the following hypotheses. First, depressive symptoms would increase from 
young-old to oldest-old age. Second, age-related increases in depressive symptoms would be 
associated with the presence/incidence of arthritis. Third, age-related changes in depressive 
symptoms would be significant predictors of death. Specifically, we hypothesized that age-
related increase in the level and slope of depressive symptoms would each be associated with 
increased risks of mortality. Finally, drawing from the results of decreasing gender difference in 
depressive symptoms from young-old to old-old from a longitudinal sample (Barefoot et al., 
2001), we hypothesized that women in general would show a higher level of depressive 
symptoms than men. However, gender differences in depressive symptoms would be smaller in 
oldest-old than in young-old adults. 
Method 
Participants 
 This study used data from the Australian Longitudinal Study of Ageing (ALSA; Luszcz 
et al., 2014). Potential participants were randomly selected from the South Australian Electoral 
Roll, for which registration is compulsory for Australian citizens. The sampling procedure and 
sample characteristics have been described elsewhere (Andrews, Clark, & Luszcz, 2002). In brief, 
individuals aged 70 years or more registered on the Electoral Roll were eligible for the study. A 
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total of 1,477 (56%) eligible people took part in Wave 1 in 1992. Spouses of participants who 
were 65 years or older and co-residents over 70 years of age were also invited to participate. At 
baseline, 2,087 older adults (M age = 78.16 years, SD = 6.69 years, age range = 64.90-103.50 
years, women = 49.4%) took part. The measures pertinent to the present study were collected on 
five occasions: Wave 1 (September, 1992-February, 1993), Wave 3 (September, 1994-February, 
1995), Wave 6 (September, 2000-February, 2001), Wave 7 (September, 2003-April, 2004), and 
Wave 9 (November, 2007-June, 2008). In addition, participants’ survival status was based on the 
date of death obtained and censored at February 2012, from the Births, Deaths and Marriages 
Registration Office, South Australia (see Anstey, Luszcz, Giles, & Andrews, 2001 for details). 
At that time, 1,721 (82.46%) participants were dead.  
Measures 
Depressive symptoms. The 20-item Center for Epidemiologic Studies Depression Scale 
was used to assess depressive symptoms (CES-D; Radloff, 1977). Participants rated their 
depressive symptoms in the last two weeks on a 4-point scale (0 = Rarely or none of the time; 3 
= Most or all of the time). The possible scores range from 0-60. Higher scores indicate greater 
degrees of depressed mood. Mean substitution was performed when less than 20 percent of 
responses were missing. Cronbach’s alphas ranged from .78 in Wave 1 to .84 in Wave 3, 
suggesting satisfactory internal consistency across waves. Table 1 presents descriptive statistics 
of depressive symptoms by waves.  
Arthritis diagnosis. At each wave, participants reported whether or not they received a 
current arthritis diagnosis from their doctors. In Wave 1, 54% of participants reported a current 
arthritis diagnosis. The proportion of participants reporting an arthritis diagnosis in our study was 
comparable to results of the National Health Interview Survey, which 49.7% of participants aged 
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65 years or above reported an arthritis diagnosis (Centers for Disease Control and Prevention, 
2013). Table 1 presents the percentages of participants who reported an arthritis diagnosis at 
each wave.  
Survival status. Survival status was established by participants’ exact date of death, 
obtained from the Births, Deaths and Marriages Registration Office, South Australia. The mean 
age of death was 87.80 years (SD = 6.33 years; range = 68.9-109.2 years). The age of death 
differed significantly between men (87.30 years) and women (88.41 years), t(1604) = -3.58, p 
< .001. 
Covariates. The effects of education, marital status, living arrangement, cognitive 
function, and illness burden were controlled for in the models examined. At Wave 1, education 
was assessed in terms of whether participants stayed in school beyond age 14 (0 = left school; 1 
= stayed in school); 44% of participants stayed in school beyond age 14. Cognitive function was 
assessed using the Mini Mental State Examination (MMSE; Folstein, Folstein, & McHugh, 
1975). Illness burden was assessed using the number of medical conditions, assessed by 
responses to questions on a comprehensive list of 37 diseases, and difficulties with activities of 
daily living. Table 1 shows the descriptive statistics for the covariates.  
Statistical Analyses  
Joint modeling of longitudinal change and survival allows the simultaneous estimation of 
longitudinal and survival information (Rizopoulos, 2012). The joint model is specified by 
treating the longitudinal and the survival models as two sub-models, with an association 
parameter, α, to link up the two sub-models. Interested researchers may refer to Rizopoulos’ 
(2012) work and its associated web resources, http://jmr.r-forge.r-project.org, for details of the 
theory and application of joint modeling.  
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To examine the association between age-related changes in depressive symptoms on 
mortality, chronological age was used to represent developmental time. The basic longitudinal 
sub-model can be represented as follows: 
Level-1 model: 
 
0 1it i i it itD b b age e    
 
(1) 
Level-2  model: 
 
0 00 0i ib a u   
1 10 1i ib a u   
(2) 
itD  is depressive symptom for individual i at time t. Following previous studies (Ghisletta, 
2008; Ghisletta et al., 2006), age is grand-mean centered at 64.90 years, the age of the youngest 
participant at Wave 1. 00a  and 10a  are fixed effects, which respectively represent the mean 
intercept and the mean effect of age on depressive symptoms. 0iu  and 1iu  are random effects, 
which respectively represent the individual-specific variations from the means. We also 
examined the effects of gender, gender by age interaction, and the quadratic effect of age. Joint 
modeling of longitudinal and survival sub-models requires parametric models (Ghisletta et al., 
2006; Rizopoulos, 2012). Therefore, the widely used non-parametric Cox survival model cannot 
be used. We used the Weibull survival model, a commonly used parametric model for survival 
functions (Therneau & Grambsch, 2000). The basic Weibull survival model can be represented 
using the following equation: 
 1
0( ) (r t )exp( )
r
i t 
   (3) 
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The term 
1r tr  is the Weibull hazard function with r > 0. r is the shape parameter. When 
r = 1, the Weibull model reduces to the exponential model. In the exponential model, the risk that 
the event occurs is constant across time. When r > 1, the risk of the event occurring increases 
with time. In contrast, When 0 < r < 1, the risk of the event occurring decreases with time. ( )i t  
is the relative risk at time t, for individual i. 0  is the intercept. Chronological age was used as 
the time metric, t, which is grand-mean centerd at 64.90 years, the age of the youngest 
participant at Wave 1. In the basic joint model, the two basic sub-models (Eqs. 1, 2, and 3) are 
linked up by the association parameter,   (Rizopoulos, 2012). 
 1
0( ) (r t )exp{ (t)}
r
i it m  
   , (4) 
where 00 0 10 1(t) ( )agei i i itm a u a u    .  
In this basic joint model represented by Eq. 4, the fitted longitudinal value, i.e., age-
related trajectory of depressive symptoms, is associated with the hazard rate. The association 
parameter,  , represents the effect of the current values of the longitudinal measures of 
depressive symptoms on the risk of death. In the next step, all baseline covariates, including 
gender and education, were added into the survival sub-model and all time-varying covariates, 
including marital status, living arrangement, cognitive functioning, and illness burden, were 
added into the longitudinal sub-model. Finally, arthritis diagnosis was entered into the 
longitudinal sub-model.  
Results 
As a first step, we tested a series of multilevel models to examine the functional form of 
the longitudinal trajectory before fitting the joint models of longitudinal and survival data. This 
determines the relative fit of a linear vs. a curvilinear model of age on depressive symptoms. The 
linear and quadratic effects for age, gender, and the interaction effect for age × gender were 
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examined. All control variables, including education, living arrangement, marital status, 
cognitive functioning, and illness burden, were entered in this model. The best fitting model 
showed that depressive symptoms increased with age, 10a  = .09, t(2605) = 4.85, p < .001. In 
addition, women reported more depressive symptoms than men, 01a  = 2.47, t(2023) = 4.51, p 
< .001. However, the effects of age and gender need to be interpreted in the context of the 
significant age × gender interaction, 11a  = -.13, t(2605) = -3.90, p < .001. Compared to women, 
men showed a steeper rate of increase in depressive symptoms. An alternative model showed 
that the quadratic effect of age was not significant, 20a  = -.001, t(2604) = -.71, p > .05. 
Additional preliminary analyses were performed to determine the effects of age, gender, and 
arthritis on depressive symptoms across waves. This information is available as an online 
supplement. Results of multilevel modeling showed that the effects of age, gender and the 
interaction of age × gender need to be considered in the longitudinal sub-model of the joint 
model, which is an important precondition to proceeding to the next step.  
We then proceeded to address the hypotheses, regarding (a) the examination of age-
related changes in depressive symptoms taking into account (changes in) cognitive function, 
illness burden, arthritis, and mortality, and (b) gender differences in age-related changes in 
depressive symptoms. Table 2 presents the parameter estimates of two joint models of 
longitudinal and survival data. Model 1 examined the effects of age, gender, and age × gender 
interaction, with time-varying covariates added in the longitudinal sub-model and baseline 
covariates added in the survival sub-model. Results of the longitudinal sub-model of Model 1 are 
graphically presented in Figure 1a. Model 2 examined the effect of arthritis diagnosis, above and 
beyond the effects examined in Model 1. An additional model adding the quadratic effect of age 
to Model 2 was fitted but could not be estimated due to model complexity. Based on AIC and 
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BIC, Model 1 provided the best fit. Results of the likelihood ratio test showed that the more 
complicated Model 2 did not fit significantly better than Model 1, χ2(1) = .65, p > .05. However, 
because of our interest in the association between arthritis diagnosis and depressive symptoms, 
results of Model 2 were used for further interpretation. Results of the longitudinal sub-model of 
Model 2 are graphically presented in Figure 1b. Depressive symptoms increased with age, 10a  
= .11, z = 6.68, p < .001. For gender differences, women reported more depressive symptoms 
than men, 01a  = 2.40, z = 5.36, p < .001. The age by gender interaction effect was significant, 11a  
= -.14, z = -5.35, p < .001. The interaction effect indicates that compared to women, men showed 
larger increases in depressive symptoms with age. In addition, individuals with a current arthritis 
diagnosis reported more depressive symptoms, 20a  = .55, z = 3.02, p < .01.  
All control variables were significantly associated with both the level and slope of 
depressive symptoms, all ps < .05. Briefly, a higher level of depressive symptoms was associated 
with individuals who were not married, living in the community, having lower cognitive function, 
greater illness burden, and more difficulties in activities of daily living. In addition, a faster rate 
of increase in depressive symptoms was associated with lower cognitive functioning, more 
medical conditions, and more difficulties in activities in daily living. 
In the survival sub-model of Model 2, the effects of gender, and number of medical 
conditions significantly predicted the risk of death. Compared to men, women had a lower risk of 
dying, 1  = -.30, z = -6.10, p < .001. The effect of education on the risk of dying was not 
significant, 2  = -.02, z = -.40, p > .05. The association parameter,   = .02, z = 5.14, p < .001, 
indicated that the age-related changes in depressive symptoms were positively associated with 
mortality, such that exp ( ) = 1.02, denotes the ratio of hazards for one unit change in the 
trajectory at any time. Specifically, a one-unit increase in the level (i.e., intercept) and an annual 
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increase of one-unit (i.e., slope) in depressive symptoms were associated respectively with 1.17- 
and 1.002-fold increase in relative risk of death. The logarithm of the shape parameter, log(shape) 
= 1.39, z = 70.88, p < .001, indicates that the risk of death increases with advancing age. 
Although the relative fit between the multilevel model and the joint models cannot be compared 
using the model fit indices, the significant effect of the association parameter,  , suggests that 
attrition due to mortality was nonrandom and was associated with the longitudinal trajectory of 
depressive symptoms.  
Discussion 
  The present study examined age-related trajectories of depressive symptoms and their 
association with mortality in old and very old age taking into consideration pathology-related 
changes to extend and qualify previous findings regarding the so-called paradox of well-being in 
old age. Four major findings emerged from this study. First, in contrast to propositions of the 
paradox of well-being, depressive symptoms increased from young-old to oldest-old age. Second, 
the level of depressive symptoms was associated with arthritis diagnosis. Individuals with 
arthritis reported a higher level of depressive symptoms than those without arthritis. Third, both 
the level of, and change in, depressive symptoms were associated with mortality, suggesting 
poorer emotional functioning as death approaches. Fourth, the significant age by gender 
interaction on depressive symptoms indicated that depressive symptoms increased with age but 
the increase was more pronounced in men than women. This suggests that emotional well-being 
may be better in men than in women in young-old age, but in very old age steeper increases in 
depressive symptoms among men first reduce and then reverse the earlier gender difference. 
These findings suggest that changes in depressive symptoms in old age are age-, pathology-, and 
mortality-related. 
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Depressive Symptoms and Age 
Consistent with findings from the Florida Retirement Study (Zhang et al., 2009), our 
results showed an increase in depressive symptoms as individuals get older. Our results advance 
those reported from the Florida Retirement Study in that we examined trajectories of depressive 
symptoms as a function of chronological age, rather than time-in-study. This allowed us to 
address the question of whether depressive symptoms change as individuals get older (rather 
than with the passage of time regardless of age). Consistent with previous studies (Kessler, 
Foster, Webster, & House, 1992; Schilling et al., 2013; Zarit et al., 1999; Zhang et al., 2009), our 
findings suggest that depressive symptoms increase from the young-old to the oldest-old. Thus, 
our findings are in support of the increasingly less favorable gain-loss dynamic wherein older 
age is associated with compromised emotional well-being (Baltes & Smith, 2003).  
Depressive Symptoms and Pathology 
The World Health Organization World Health Survey (Moussavi et al., 2007) examined 
the self-report of depressive symptoms in individuals with different chronic disorders in a sample 
of over 240,000 participants from 60 countries. Results showed that individuals with arthritis had 
a higher one-year prevalence of depressive episode (based on the cut-off score of depressive 
symptoms in the past 12 months), 4.1%, compared to the average of 3.2%. Specifically, the one-
year prevalence of depressive episode in individuals with arthritis ranked second, compared to 
individuals with angina (4.5%), asthma (3.3%), and diabetes (2.0%). Approximately half of the 
participants in the present study reported having a current diagnosis of arthritis at some point 
over the 15 year period. In addition to the high prevalence rate, arthritis is a very painful and 
disabling health condition (Dexter & Brandt, 1994). Although the present study did not include 
measures of participants’ pain and arthritis severity, our findings point to the importance of 
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vulnerabilities to low emotional well-being in individuals with arthritis and chronic pain in 
general (Schmitz, Saile, & Nilges, 1996).  
Depressive Symptoms and Mortality 
In line with findings from the Florida Retirement Study (Zhang et al., 2009), the observed 
developmental trajectory of depressive symptoms was associated with an increase in the risk of 
death. However, the use of chronological age, rather than time-in-study, as the time metric in the 
present study rendered our results not directly comparable to the Florida Retirement Study. 
Nonetheless, our findings are consistent with reports from the cognitive domain showing that 
between-person differences in the level of, and age-related changes in, multiple cognitive 
functions are associated with mortality (Ghisletta, 2008; Ghisletta et al., 2006). Likewise, past 
findings revealed that multiple dimensions of emotional well-being are associated with mortality, 
e.g. life satisfaction, depressive symptoms, and negative affect (Anstey & Luszcz, 2002; Gerstorf 
et al., 2008; Gerstorf et al., 2010; Schilling, Wahl, & Wiegering, 2012; Zhang et al., 2009). It 
would be highly instructive if future studies were to examine whether the age-related changes in 
multiple dimensions of emotional well-being (i.e., cognitive vs. affective components of 
subjective well-being, and somatic vs. non-somatic depressive symptoms) are differentially 
associated with mortality (Gana et al., 2013; Schilling, 2006). In terms of clinical implications, 
individuals reporting more depressive symptoms may be more likely to engage in unhealthy 
behaviors and have less social support, thus leading to a higher risk of mortality (Giles, Glonek, 
Luszcz, & Andrews, 2005; Schulz, Martire, Beach, & Scheier, 2000). Given the demographic 
projections of increases in the number of older and oldest-old adults in particular (Suzman, 
Willis, & Manton, 1992), the societal burden of rising depressive symptoms in old age is 
concerning. Our findings suggest that recognition of depressive symptoms in older adults and 
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early interventions are imperative to enhance the quality of life in advanced old age (Mastel-
Smith, McFarlane, Sierpina, Malecha, & Haile, 2007). 
Gender and Depressive Symptoms 
 Gender differences in the level and rate of change in depressive symptoms were the final 
focus of our study. Consistent with findings from a Danish sample (Barefoot et al., 2001), we 
found a significant age by gender interaction on depressive symptoms. Specifically, the rate of 
change in depressive symptoms was steeper in men such that in young-old age, men reported a 
lower level of depressive symptoms than women. However, the gender difference reduced and 
then reversed with increasing age, with men reporting higher levels of depressive symptoms than 
women in very old age. Gender differences in social networking and social support, as well as 
variations in coping styles may explain the reversed gender gap in depressive symptoms in 
advanced old age (Aldwin, Spiro, & Park, 2006). It may be that men more than women are likely 
to use problem-focused coping rather than emotion-focused coping (Tamres, Janicki, & 
Helgeson, 2002). The changing life circumstances from young-old to oldest-old age may render 
the use of problem-focused coping less effective in maintaining emotional well-being (Lazarus & 
Folkman, 1984). For example, chronic health constraints pose difficulties in everyday 
functioning in old age and may not be readily resolved and may instead be denied. In contrast, 
the use of emotion-focused coping such as empathy may better enable women to come to terms 
with the losses that are outside of the control of an older adult and that therefore cannot be fixed 
using problem-focused coping, such as death of spouse or  loss of independence, in advanced old 
age (Diehl et al., 2014). Thus, our findings point toward a potential source of vulnerability in 
older men, when life circumstances in advanced old age may call for coping styles that they are 
less accustomed to using.    
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Significance of the Current Study 
 Our findings revealed that both the level of, and changes in, depressive symptoms were 
associated with risk of death. Importantly, estimates of age-related changes in depressive 
symptoms from joint modeling take attrition due to mortality into account, thus giving a less 
biased picture of the development of depressive symptoms in old age (Graham et al., 2011; 
Rizopoulos, 2012). This is consistent with the possibility that past findings that ignore 
nonrandom dropout due to mortality may underestimate the age-related declines in life 
satisfaction (Mroczek & Spiro III, 2005). Our study extended earlier findings of gender 
differences in depressive symptoms (Barefoot et al., 2001; Nolen-Hoeksema, Larson, & Grayson, 
1999). By including old-old and oldest-old adults in our large sample, the age by gender 
interaction effect indicates that gender gap in depressive symptoms reduced from young-old to 
old-old and reversed at the extremes of old age.  
Limitations and Outlook 
The present study is unique in that we use 15-year longitudinal data from a very old 
sample and recent advances in statistical techniques for longitudinal analysis. However, our 
findings should be considered in light of several limitations. First, the present study is limited by 
the lack of clinical assessments of depression, illness burden, and cause of mortality. Previous 
studies suggest that clinical assessments of severe medical conditions (such as cancer and 
coronary heart diseases), and causes of death are possibly associated with the age-related and 
mortality-related processes and shape depressive symptom trajectories in old age (Anstey, Mack, 
& von Sanden, 2006; Bäckman & MacDonald, 2006; Sliwinski et al., 2006; Small, Fratiglioni, 
von Strauss, & Bäckman, 2003). Of note though is that the self-reported number of medical 
conditions also was a significant predictor of mortality. This suggests that self-reports of illness 
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burden such as the number of medical conditions may be a useful proxy to quantify individuals’ 
health status (Lee, 2000). In addition, a substantial body of literature has examined the 
association between depressive symptoms and a myriad of medical diagnoses in clinical samples, 
including macular degeneration, diabetes, cancer, cardiac diseases, and comorbidity of multiple 
chronic health conditions (Ciechanowski, Katon, & Russo, 2000; Rovner, Casten, Hegel, Leiby, 
& Tasman, 2007). Future research may further validate our findings by including clinical 
assessments of illness burden, and biological markers of health, such as stress response and 
immunological functioning (Franceschi et al., 2000), in the examination of longitudinal 
development of depressive symptoms.  
Second, the use of a heterogeneous sample in terms of age at baseline (64.9-103.5 years) 
and an extended follow-up period allowed the examination of age-related changes in depressive 
symptoms from young-old to oldest-old age. However, in contrast to the 11 yearly assessments 
in the Florida Retirement Study (Zhang et al., 2009), the intervals between the five waves of our 
longitudinal study were uneven and more widely spaced in later waves. Past findings indicate a 
curvilinear pattern of age-related changes in depressive symptoms (Clarke et al., 2011) and 
abrupt changes in life satisfaction and affective well-being at about 4-7 years before death 
(Gerstorf et al., 2008; Gerstorf et al., 2010; Schilling et al., 2012). It is possible that the more 
widely spaced intervals in the present study are less than optimal to capture the quadratic effect 
of age on depressive symptoms. Nevertheless, our findings were similar to that of the Florida 
Retirement Study, such that no accelerated time-in-study effect, i.e. quadratic effect of time-in-
study, in depressive symptoms was observed.  
Third, our sample did not include young and middle aged adults. We cannot extrapolate 
our findings to the earlier stages of human development, nor to these participants’ previous 
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experiences. Thus, our findings are limited in addressing questions regarding the lifespan 
development of depressive symptoms. For example, our findings cannot address questions of 
late-life depression that may originate in early adulthood (Blazer & Hybels, 2005; Clarke et al., 
2011). Nonetheless, our findings are conceptually in keeping with the lifespan development 
framework (Baltes et al., 2006). In addition, our results pertain to depressive symptoms and may 
not be generalizable to age-related changes in the rates of clinical depression. Future studies are 
needed to examine the lower rates of diagnosed clinical depression in late-life compared to 
young adults (Blazer & Hybels, 2005).   
Fourth, the present study cannot tease apart the cause-and-effect associations between 
depressive symptoms and changes associated with age, pathology, and mortality. Instead of the 
integrative approach adopted in the present study, recent research examined the effects of age, 
pathology, and mortality on depressive symptoms in separate models (Fauth et al., 2014). Results 
showed that age, pathology, and mortality each explain changes in depressive symptoms, 
although to varying degrees. Our findings likewise suggest that, even though the increase in the 
relative risk in mortality is small, the developmental trajectory of depressive symptoms is a 
function of age-, pathology-, and mortality-related processes. Future research might include a 
lead/lag effect of pathology to examine the cause-and-effect relationship between pathology and 
depression.  
Conclusion 
The present study complements and extends a growing body of research by suggesting 
that depressive symptoms increase from young-old to oldest-old age and that the age-related 
trajectory of depressive symptoms is associated with increased likelihood of mortality. These 
findings converge with results from the literature that late life and its increasingly less favorable 
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gain-loss dynamic may challenge individuals’ well-being (Baltes & Smith, 2003). Subgroups of 
oldest-old adults are likely to experience qualitatively different vulnerabilities, such that 
individuals of low physical functioning may be predisposed to a higher level of, and more rapid 
increase in, depressive symptoms (Schilling et al., 2013). Although some dimensions of 
emotional well-being may be maintained or improved through advanced old age, age-related 
vulnerabilities such as chronic health conditions may render the implementation of coping and 
self-regulation strategies difficult if not impossible, thus leading to the age-related increase in 
depressive symptoms (Charles, 2010). Some interventions, such as problem-solving treatment, 
may alleviate the effect of chronic health conditions for a short-term (Rovner et al., 2007). 
Specifically, evidence showed that problem-solving treatment prevented depressive disorders in 
a sample of older adults with recent diagnoses of macular degeneration two months after the 
treatment program, but not in the long-term, i.e. six months later (Rovner et al., 2007). Future 
studies are needed to evaluate the long-term effect of treatment to alleviate depressive symptoms 
in older adults. For example, evidence has shown that volunteering interventions designed to 
enhance generativity, such as Experience Corps, have increased physical, cognitive, and social 
activities in older adults (Fried et al., 2004). Future research may investigate which types and 
aspects of volunteering may promote social and psychological resources to reduce depressive 
symptoms in older adults (Borgonovi, 2008; Musick & Wilson, 2003). Furthermore, studies on 
life-review intervention may illuminate how to enhance wisdom and reduce depressive 
symptoms in old age (Daniels, Boehnlein, & McCallion, 2015). Social policies and aging-
friendly support structures, such as the provision of public transport and access to (ambulatory) 
healthcare services for older adults (National Aged Care Alliance, 2007), are needed to target  
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oldest-old adults as a whole, but also subgroups of oldest-old adults who need support services 
most.  
 
Depressive Symptoms, Pathology, and Mortality 27 
References 
Alberta Health. (2003). Chronic pain in Alberta: A portrait from the 1996 National Population 
Health Survey and the 2001 Canadian Community Health Survey.  Edmonton, Alberta:  
Retrieved from http://www.health.alberta.ca/documents/Chronic-Pain-Survey-2003.pdf. 
Aldwin, C. M., & Gilmer, D. F. (2013). Health, illness, and optimal aging: Biological and 
psychosocial perspectives (2nd ed.). Thousand Oaks: Sage. 
Aldwin, C. M., Spiro, A., III, & Park, C. L. (2006). Health, behavior, and optimal aging: A life 
span developmental perspective. In J. E. Birren & K. W. Schaire (Eds.), Handbook of the 
psychology of aging (6th ed.) (pp. 85-104). Amsterdam, Netherlands: Elsevier. 
Alexopoulos, G. S. (2005). Depression in the elderly. The Lancet, 365(9475), 1961-1970. doi: 
10.1016/s0140-6736(05)66665-2 
Andrews, G., Clark, M., & Luszcz, M. (2002). Successful aging in the Australian Longitudinal 
Study of Aging: Applying the MacArthur Model cross-nationally. Journal of Social 
Issues, 58, 749-765. doi: 10.1111/1540-4560.00288 
Anstey, K. J., & Luszcz, M. A. (2002). Mortality risk varies according to gender and change in 
depressive status in very old adults. Psychosomatic Medicine, 64, 880-888. doi: 
10.1097/01.psy.0000028827.64279.60 
Anstey, K. J., Luszcz, M. A., Giles, L. C., & Andrews, G. R. (2001). Demographic, health, 
cognitive, and sensory variables as predictors of mortality in very old adults. Psychology 
and Aging, 16, 3-11. doi: 10.1037/0882-7974.16.1.3 
Anstey, K. J., Mack, H. A., & von Sanden, C. (2006). The relationship between cognition and 
mortality in patients with stroke, coronary heart disease, or cancer. European 
Psychologist, 11, 182-195. doi: 10.1027/1016-9040.11.3.182 
Depressive Symptoms, Pathology, and Mortality 28 
Anstey, K. J., von Sanden, C., Sargent-Cox, K., & Luszcz, M. A. (2007). Prevalence and risk 
factors for depression in a longitudinal, population-based study including individuals in 
the community and residential care. American Journal of Geriatric Psychiatry, 15, 497-
505. doi: 10.1097/JGP.0b013e31802e21d8 
Australian Government. (2010). A snapshot of arthritis in Australia 2010 Arthritis series (Vol. 
13). Canberra: Australian Institute of Health and Welfare. 
Australian Institute of Health and Welfare. (2014). Australia's health 2014 Australia's health 
series (Vol. 14). Canberra: Australian Institute of Health and Welfare. 
Bäckman, L., & MacDonald, S. W. S. (2006). Death and cognition: Viewing a 1962 concept 
through 2006 spectacles. European Psychologist, 11, 161-163. doi: 10.1027/1016-
9040.11.3.161  
Baltes, P. B. (1997). On the incomplete architecture of human ontogeny: Selection, optimization, 
and compensation as foundation of developmental theory. American Psychologist, 52(4), 
366-380.  
Baltes, P. B., Lindenberger, U., & Staudinger, U. M. (2006). Life span theory in developmental 
psychology. In R. M. Lerner & W. Damon (Eds.), Handbook of child psychology (6th 
ed.): Vol 1, Theoretical models of human development. (pp. 569-664). Hoboken, NJ: 
Wiley. 
Baltes, P. B., & Smith, J. (2003). New frontiers in the future of aging: From successful aging of 
the young old to the dilemmas of the fourth age. Gerontology, 49, 123-135. doi: 
10.1159/000067946 
Depressive Symptoms, Pathology, and Mortality 29 
Barefoot, J. C., Mortensen, E. L., Helms, M. J., Avlund, K., & Schroll, M. (2001). A longitudinal 
study of gender differences in depressive symptoms from age 50 to 80. Psychology and 
Aging, 16, 342-345. doi: 10.1037/0882-7974.16.2.342  
Berg, S. (1996). Aging, behavior, and terminal decline. In J. E. Birren & K. W. Schaie (Eds.), 
Handbook of the psychology of aging (4th ed., pp. 323-337). New York, US: Academic 
Press. 
Birren, J. E., & Cunningham, W. (1985). Research on the psychology of aging: Principles, 
concepts, and theory. In J. E. Birren & K. W. Schaie (Eds.), Handbook of the psychology 
of aging (2nd ed., pp. 3-34). New York, NY: Van Nostrand Reinhold. 
Blazer, D. G. (2003). Depression in late life: Review and commentary. Journals of Gerontology: 
Biological Sciences and Medical Sciences, 58A, 249-265. doi: 10.1093/gerona/58.3.M249  
Blazer, D. G., & Hybels, C. F. (2005). Origins of depression in later life. Psychological Medicine, 
35, 1241-1252. doi: 10.1017/s0033291705004411 
Borgonovi, F. (2008). Doing well by doing good. The relationship between formal volunteering 
and self-reported health and happiness. Social Science and Medicine, 66, 2321-2334. doi: 
10.1016/j.socscimed.2008.01.011 
Byers, A. L., Vittinghoff, E., Lui, L.-Y., Hoang, T., Blazer, D. G., Covinsky, K. E., . . . Yaffe, K. 
(2012). Twenty-year depressive trajectories among older women. Archives of General 
Psychiatry, 69, 1073-1079. doi: 10.1001/archgenpsychiatry.2012.43 
Carstensen, L. L., Turan, B., Scheibe, S., Ram, N., Ersner-Hershfield, H., Samanez-Larkin, G. 
R., . . . Nesselroade, J. R. (2011). Emotional experience improves with age: Evidence 
based on over 10 years of experience sampling. Psychology and Aging, 26, 21-33. doi: 
10.1037/a0021285 
Depressive Symptoms, Pathology, and Mortality 30 
Caughey, G. E., Ramsay, E. N., Vitry, A. I., Gilbert, A. L., Luszcz, M. A., Ryan, P., & Roughead, 
E. E. (2010). Comorbid chronic diseases, discordant impact on mortality in older people: 
A 14-year longitudinal population study. Journal of Epidemiology and Community 
Health, 64, 1036-1042. doi: 10.1136/jech.2009.088260 
Centers for Disease Control and Prevention. (2013). Prevalence of doctor-diagnosed arthritis and 
arthritis-attributable activity limitation — United States, 2010–2012. Morbidity and 
Mortality Weekly Report, 62, 869-873.  
Charles, S. T. (2010). Strength and vulnerability integration: A model of emotional well-being 
across adulthood. Psychological Bulletin, 136, 1068-1091. doi: 10.1037/a0021232 
Charles, S. T., & Carstensen, L. L. (2010). Social and emotional aging. Annual Review of 
Psychology, 61, 383-409. doi: 10.1146/annurev.psych.093008.100448 
Charles, S. T., Reynolds, C. A., & Gatz, M. (2001). Age-related differences and change in 
positive and negative affect over 23 years. Journal of Personality and Social Psychology, 
80, 136-151. doi: 10.1037/0022-3514.80.1.136 
Ciechanowski, P. S., Katon, W. J., & Russo, J. E. (2000). Depression and diabetes: Impact of 
depressive symptoms on adherence, function, and costs. Archives of Internal Medicine, 
160, 3278-3285. doi: 10.1001/archinte.160.21.3278 
Clarke, P., Marshall, V., House, J., & Lantz, P. (2011). The social structuring of mental health 
over the adult life course: Advancing theory in the sociology of aging. Social Forces, 89, 
1287-1313. doi: 10.1093/sf/89.4.1287 
Daniels, L. R., Boehnlein, J., & McCallion, P. (2015). Aging, Depression, and Wisdom: A Pilot 
Study of Life-Review Intervention and PTSD Treatment With Two Groups of Vietnam 
Veterans. J Gerontol Soc Work, 1-17. doi: 10.1080/01634372.2015.1013657 
Depressive Symptoms, Pathology, and Mortality 31 
Dexter, P., & Brandt, K. (1994). Distribution and predictors of depressive symptoms in 
osteoarthritis. Journal of Rheumatology, 21, 279-286.  
Diehl, M., Chui, H., Hay, E. L., Lumley, M. A., Grühn, D., & Labouvie-Vief, G. (2014). Change 
in coping and defense mechanisms across adulthood: Longitudinal findings in a European 
American sample. Developmental Psychology, 50, 634-648. doi: 10.1037/a0033619 
Diener, E., Suh, E. M., Lucas, R. E., & Smith, H. L. (1999). Subjective well-being: Three 
decades of progress. Psychological Bulletin, 125, 276-302. doi: 10.1037/0033-
2909.125.2.276 
Fauth, E. B., Gerstorf, D., Ram, N., & Malmberg, B. (2014). Comparing Changes in Late-Life 
Depressive Symptoms Across Aging, Disablement, and Mortality Processes. 
Developmental Psychology. doi: 10.1037/a0035475 
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). "Mini-mental state": A practical 
method for grading the cognitive state of patients for the clinician. Journal of Psychiatric 
Research, 12, 189-198. doi: 10.1016/0022-3956(75)90026-6 
Franceschi, C., Motta, L., Valensin, S., Rapisarda, R., Franzone, A., Berardelli, M., . . . Baggio, 
G. (2000). Do men and women follow different trajectories to reach extreme longevity? 
Italian Multicenter Study on Centenarians (IMUSCE). Aging Clinical and Experimental 
Research, 12, 77-84. doi: 10.1007/BF03339894 
Fried, L. P., Carlson, M. C., Freedman, M., Frick, K. D., Glass, T. A., Hill, J., . . . Zeger, S. 
(2004). A social model for health promotion for an aging population: Initial evidence on 
the Experience Corps model. Journal of Urban Health, 81, 64-78. doi: 
10.1093/jurban/jth094 
Depressive Symptoms, Pathology, and Mortality 32 
Gana, K., Bailly, N., Saada, Y., Joulain, M., & Alaphilippe, D. (2013). Does life satisfaction 
change in old age: Results from an 8-year longitudinal study. The Journals of 
Gerontology Series B: Psychological Sciences and Social Sciences, 68, 540-552. doi: 
10.1093/geronb/gbs093 
Gerstorf, D., & Ram, N. (2013). Inquiry into terminal decline: Five objectives for future study. 
The Gerontologist, 53, 727-737. doi: 10.1093/geront/gnt046 
Gerstorf, D., Ram, N., Lindenberger, U., Röcke, C., & Smith, J. (2008). Decline in life 
satisfaction in old age: Longitudinal evidence for links to distance-to-death. Psychology 
and Aging, 23, 154-168. doi: 10.1037/0882-7974.23.1.154 
Gerstorf, D., Ram, N., Lindenberger, U., & Smith, J. (2013). Age and time-to-death trajectories 
of change in indicators of cognitive, sensory, physical, health, social, and self-related 
functions. Developmental Psychology, 49, 1805-1821. doi: 10.1037/a0031340 
Gerstorf, D., Ram, N., Mayraz, G., Hidajat, M., Lindenberger, U., Wagner, G. G., & Schupp, J. 
(2010). Late-life decline in well-being across adulthood in Germany, the United 
Kingdom, and the United States: Something is seriously wrong at the end of life. 
Psychology and Aging, 25, 477-485. doi: 10.1037/a0017543  
Ghisletta, P. (2008). Application of a joint multivariate longitudinal-survival analysis to examine 
the terminal decline hypothesis in the Swiss Interdisciplinary Longitudinal Study on the 
Oldest Old. The Journals of Gerontology: Psychological Sciences and Social Sciences, 
63B, P185-P192. doi: 10.1093/geronb/63.3.P185 
Ghisletta, P., McArdle, J. J., & Lindenberger, U. (2006). Longitudinal cognition-survival 
relations in old and very old age: 13-year data from the berlin aging study. European 
Psychologist, 11, 204-223. doi: 10.1027/1016-9040.11.3.204 
Depressive Symptoms, Pathology, and Mortality 33 
Giles, L. C., Glonek, G. F. V., Luszcz, M. A., & Andrews, G. R. (2005). Effect of social 
networks on 10 year survival in very old Australians: the Australian longitudinal study of 
aging. Journal of Epidemiology and Community Health, 59, 574-579. doi: 
10.1136/jech.2004.025429 
Graham, P. L., Ryan, L. M., & Luszcz, M. A. (2011). Joint modelling of survival and cognitive 
decline in the Australian Longitudinal Study of Ageing. Journal of the Royal Statistical 
Society: Series C (Applied Statistics), 60, 221-238. doi: 10.1111/j.1467-
9876.2010.00737.x 
Hootman, J. M., Helmick, C. G., & Brady, T. J. (2012). A public health approach to addressing 
arthritis in older adults: the most common cause of disability. American Journal of Public 
Health, 102, 426-433. doi: 10.2105/ajph.2011.300423 
Infurna, F. J., Gerstorf, D., & Ram, N. (2013). The nature and correlates of change in depressive 
symptoms with cancer diagnosis: Reaction and adaptation. Psychology and Aging, 28, 
386-401. doi: 10.1037/a0029775 
Kessler, R. C., Foster, C., Webster, P. S., & House, J. S. (1992). The relationship between age 
and depressive symptoms in two national surveys. Psychology and Aging, 7, 119-126. doi: 
10.1037/0882-7974.7.1.119  
Kunzmann, U., Little, T. D., & Smith, J. (2000). Is age-related stability of subjective well-being 
a paradox? Cross-sectional and longitudinal evidence from the Berlin Aging Study. 
Psychology and Aging, 15, 511-526. doi: 10.1037/0882-7974.15.3.511 
Lam, M., Lehman, A. J., Puterman, E., & DeLongis, A. (2009). Spouse depression and disease 
course among persons with rheumatoid arthritis. Arthritis Care and Research, 61, 1011-
1017. doi: 10.1002/art.24510 
Depressive Symptoms, Pathology, and Mortality 34 
Lazarus, R. S., & Folkman, S. (1984). Stress, Appraisal, and Coping. New York: Springer. 
Lee, Y. (2000). The predictive value of self assessed general, physical, and mental health on 
functional decline and mortality in older adults. Journal of Epidemiology and Community 
Health, 54, 123-129. doi: 10.1136/jech.54.2.123 
Luszcz, M. A., Giles, L. C., Anstey, K. J., Browne-Yung, K. C., Walker, R. A., & Windsor, T. D. 
(2014). Cohort Profile: The Australian Longitudinal Study of Ageing (ALSA). 
International Journal of Epidemiology, Advance online publication. doi: 
10.1093/ije/dyu196 
Maier, H., & Smith, J. (1999). Psychological predictors of mortality in old age. The Journals of 
Gerontology: Psychological Sciences and Social Sciences, 54B, P44-P54. doi: 
10.1093/geronb/54B.1.P44 
Marks, R. (2013). Depressive symptoms among community-dwelling older adults with mild to 
moderate knee osteoarthritis: Extent, interrelationships, and predictors. American Journal 
of Medicine Studies, 1, 11-18. doi: 10.12691/ajms-1-3-1 
Mastel-Smith, B. A., McFarlane, J., Sierpina, M., Malecha, A., & Haile, B. (2007). Improving 
depressive symptoms in community-dwelling older adults: A psychosocial intervention 
using life review and writing. Journal of Gerontological Nursing, 33(5), 13-19.  
Mather, M. (2012). The emotion paradox in the aging brain. Annals of the New York Academy of 
Sciences, 1251, 33-49. doi: 10.1111/j.1749-6632.2012.06471.x 
Mirowsky, J. (1996). Age and the gender gap in depression. Journal of Health and Social 
Behavior, 37, 362-380. doi: 10.2307/2137263 
Depressive Symptoms, Pathology, and Mortality 35 
Mirowsky, J., & Reynolds, J. R. (2000). Age, depression, and attrition in the National Survey of 
Families and Households. Sociological Methods and Research, 28, 476-504. doi: 
10.1177/0049124100028004004 
Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007). Depression, 
chronic diseases, and decrements in health: Results from the World Health Surveys. The 
Lancet, 370(9590), 851-858. doi: http://dx.doi.org/10.1016/S0140-6736(07)61415-9 
Mroczek, D. K., & Kolarz, C. M. (1998). The effect of age on positive and negative affect. 
Journal of Personality and Social Psychology, 75, 1333-1349. doi: 10.1037/0022-
3514.75.5.1333 
Mroczek, D. K., & Spiro III, A. (2005). Change in life satisfaction during adulthood: Findings 
from the Veterans Affairs Normative Aging Study. Journal of Personality and Social 
Psychology, 88, 189-202. doi: 10.1037/0022-3514.88.1.189 
Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., . . . Lopez, A. 
D. (2012). Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 
regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. 
The Lancet, 380(9859), 2197-2223. doi: 10.1016/S0140-6736(12)61689-4 
Musick, M. A., & Wilson, J. (2003). Volunteering and depression: The role of psychological and 
social resources in different age groups. Social Science and Medicine, 56, 259-269.  
National Aged Care Alliance. (2007). Transport and access to health care services for older 
Australians  Retrieved April 30, 2015, from 
http://www.naca.asn.au/Publications/NACA_transport_0507.pdf 
Neugarten, D. A. (Ed.). (1996). The Meanings of Age: Selected Papers of Bernice L. Neugarten 
Chicago: University of Chicago Press. 
Depressive Symptoms, Pathology, and Mortality 36 
Nolen-Hoeksema, S., Larson, J., & Grayson, C. (1999). Explaining the gender difference in 
depressive symptoms. Journal of Personality and Social Psychology, 77, 1061-1072. doi: 
10.1037/0022-3514.77.5.1061 
Pessin, H., Rosenfeld, B., & Breitbart, W. (2002). Assessing psychological distress near the end 
of life. American Behavioral Scientist, 46, 357-372. doi: 10.1177/000276402237769 
Radloff, L. S. (1977). The CES-D scale: A self report depression scale for research in the general 
population. Applied Psychological Measurement, 1, 385-401. doi: 
10.1177/014662167700100306  
Rapp, M. A., Gerstorf, D., Helmchen, H., & Smith, J. (2008). Depression predicts mortality in 
the young old, but not in the oldest old: Results from the Berlin Aging Study. American 
Journal of Geriatric Psychiatry, 16, 844-852. doi: 10.1097/JGP.0b013e31818254eb 
Rizopoulos, D. (2012). Joint models for longitudinal and time-to-event data: With applications 
in R. Boca Raton: Chapman and Hall/CRC. 
Rovner, B. W., Casten, R. J., Hegel, M. T., Leiby, B. E., & Tasman, W. S. (2007). Preventing 
depression in age-related macular degeneration. Archives of General Psychiatry, 64, 886-
892. doi: 10.1001/archpsyc.64.8.886 
Saz, P., & Dewey, M. E. (2001). Depression, depressive symptoms and mortality in persons aged 
65 and over living in the community: A systematic review of the literature. International 
Journal of Geriatric Psychiatry, 16, 622-630. doi: 10.1002/gps.396 
Schilling, O. K. (2006). Development of life satisfaction in old age: Another view on the 
‘paradox.’. Social Indicators Research, 75, 241-271. doi: 10.1007/s11205-004-5297-2 
Depressive Symptoms, Pathology, and Mortality 37 
Schilling, O. K., Wahl, H.-W., & Reidick, O. (2013). Trajectories of depressive symptoms in 
advanced old age. GeroPsych: The Journal of Gerontopsychology and Geriatric 
Psychiatry, 26, 29-38. doi: 10.1024/1662-9647/a000079 
Schilling, O. K., Wahl, H. W., & Wiegering, S. (2012). Affective development in advanced old 
age: Analyses of terminal change in positive and negative affect. Developmental 
Psychology, 49, 1011-1020. doi: 10.1037/a0028775 
Schmitz, U., Saile, H., & Nilges, P. (1996). Coping with chronic pain: Flexible goal adjustment 
as an interactive buffer against pain-related distress. Pain, 67, 41-51. doi: 10.1016/0304-
3959(96)03108-9 
Schulz, R., Martire, L. M., Beach, S. R., & Scheier, M. F. (2000). Depression and mortality in 
the elderly. Current Directions in Psychological Science, 9, 204-208. doi: 10.1111/1467-
8721.00095 
Sirois, F. M., & Hirsch, J. K. (2013). Associations of psychological thriving with coping efficacy, 
expectations for future growth, and depressive symptoms over time in people with 
arthritis. Journal of Psychosomatic Research. doi: 10.1016/j.jpsychores.2013.06.004 
Sliwinski, M. J., Stawski, R. S., Hall, C. B., Katz, M., Verghese, J., & Lipton, R. (2006). 
Distinguishing preterminal and terminal cognitive decline. European Psychologist, 11:, 
172-181. doi: 10.1027/1016-9040.11.3.172 
Small, B. J., Fratiglioni, L., von Strauss, E., & Bäckman, L. (2003). Terminal decline and 
cognitive performance in very old age: Does cause of death matter? Psychology and 
Aging, 18, 193-202. doi: 10.1037/0882-7974.18.2.193 
St John, P. D., & Montgomery, P. R. (2009). Do depressive symptoms predict mortality in older 
people? Aging and Mental Health, 13, 674-681. doi: 10.1080/13607860902774493 
Depressive Symptoms, Pathology, and Mortality 38 
Suzman, R. M., Willis, D. P., & Manton, K. G. (Eds.). (1992). The oldest old. Oxford: Oxford 
University Press. 
Tamres, L. K., Janicki, D., & Helgeson, V. S. (2002). Sex differences in coping behavior: A 
meta-analytic review and an examination of relative coping. Personality and Social 
Psychology Review, 6, 2-30. doi: 10.1207/s15327957pspr0601_1 
Tennen, H., Affleck, G. G., & Zautra, A. J. (2006). Depression history and coping with chronic 
pain: A daily process analysis. Health Psychology, 25, 370-379. doi: 10.1037/0278-
6133.25.3.370 
Therneau, T. M., & Grambsch, P. M. (2000). Modeling survival data: Extending the Cox model. 
New York, US: Springer. 
Zarit, S. H., Femia, E. E., Gatz, M., & Johansson, B. (1999). Prevalence, incidence and correlates 
of depression in the oldest old: the OCTO study. Aging and Mental Health, 3, 119-128. 
doi: 10.1080/13607869956271 
Zautra, A. J., Smith, B., Affleck, G. G., & Tennen, H. (2001). Examinations of chronic pain and 
affect relationships: Applications of a dynamic model of affect. Journal of Consulting 
and Clinical Psychology, 69, 786-795. doi: 10.1037/0022-006X.69.5.786 
Zhang, J.-P., Kahana, B., Kahana, E., Hu, B., & Pozuelo, L. (2009). Joint modeling of 
longitudinal changes in depressive symptoms and mortality in a sample of community-
dwelling elderly people. Psychosomatic Medicine, 71, 704-714. doi: 
10.1097/PSY.0b013e3181ac9bce 
  
Depressive Symptoms, Pathology, and Mortality 39 
Table 1. Means and Standard Deviations of Depressive Symptoms, and Covariates by Wave  and 
Gender 
 Wave 1  
(1992)  
n = 2,087 
Wave 3  
(1994) 
n =1,679 
Wave 6  
(2000) 
n = 791 
Wave 7  
(2003) 
n = 487 
Wave 9  
(2007) 
n = 217 
Measure M(SD) M(SD) M(SD) M(SD) M(SD) 
CES-D Men 8.02(7.20) 7.82(7.22) 8.61(6.33) 8.04(7.43) 9.47(7.64) 
 Women 8.63(7.71) 8.86(7.43) 9.40(6.88) 8.82(7.42) 10.09(6.92) 
CES-D ≥ 16 Men 14% 13% 14% 15% 25% 
 Women 16% 19% 17% 16% 18% 
Age (in years) Men 79.47(6.17) 80.88(6.04) 84.91(5.22) 86.16(4.47) 89.25(3.75) 
 Women 77.89(7.07) 79.35(6.84) 83.50(5.80) 84.98(5.04) 87.59(4.10) 
Arthritis diagnosis Men 51% 40% 40% 49% 39% 
 Women 58% 50% 53% 59% 61% 
Marital statusa Men 70% 64% 57% 57% 54% 
 Women 60% 52% 36% 26% 20% 
Living arrangementb Men 95% 91% 84% 90% 86% 
 Women 93% 90% 85% 82% 87% 
MMSE Men 26.83(4.02) 27.17(2.77) 27.87(2.50) 21.89(10.09) 23.49(9.00)  
 Women 26.92(4.40) 27.52(2.60) 28.20(2.13) 21.69(9.98) 23.70(8.46) 
Number of medical 
conditions 
Men 5.33(2.90) 4.02(2.59) 3.82(2.81) 5.10(3.04) 4.09(2.66) 
 Women 5.34(3.10) 4.28(2.58) 4.19(2.87) 5.47(3.39) 4.27(2.49) 
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Difficulties in ADL  Men .34(1.00) 1.02(1.81) 1.29(2.07) .88(1.79) .10(.38) 
 Women .41(1.10) 1.21(1.93) 1.46(2.18) .91(1.56) .32(1.22) 
% women  49.40 50.86 57.65 62.22 64.98 
Note. CES-D = Center for Epidemiologic Studies Depression Scale. MMSE = Mini Mental State 
Examination. ADL = Activities of daily living. 
aMarital status is indicated by the percentage of participants who were married or in a defacto 
relationship. 
bLiving arrangement is indicated by the percentage of participants who were community living. 
M = mean; SD = Standard deviation.  
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Table 2. Results of Age-Related Changes and Mortality from Joint Models 
 Model 1  Model 2  
 Estimate(SE)  Estimate(SE)  
Parameters from the longitudinal sub-model   
Fixed effects     
Intercept, 00a  7.77(.32)***  7.76(.32)***  
Level 1     
Agea, 10a  
.11(.02)***   .11(.02)***  
Arthritis diagnosis, 20a    .55(.18)**  
Marital status, 30a  -1.57(.19)***  -1.57(.19)***  
Living arrangement, 40a  .72(.38)  .75(.37)*  
MMSE, 50a  -.18(.04)***  -.19(.04)***  
Medical condition, 60a  .14(.04)**  .11(.04)*  
Difficulties in ADL, 70a  .59(.08)***  .59(.08)***  
Level 2     
Gender, 01a  2.41(.45)***  2.40(.45)***  
Age × Gender, 11a  -.14(.03)***  -.14(.03)***  
MMSE (BP) b, 02a  -.34(.03)***  -.34(.03)***  
Medical condition (BP), 03a  .73(.04)***  .69(.04)***  
Difficulties in ADL (BP), 04a  .97(.08)***  .95(.09)***  
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Random effectsc     
Standard deviations     
Intercept 3.52  3.50  
Age .07  .07  
Residual 4.71  4.71  
Correlation     
Intercept-age .64  .64  
Parameters from the survival sub-model   
Intercept, 0  -13.40(.27)***  -13.40(.27)***  
Gender, 1  -.30(.05)***  -.30(.05)***  
Education, 2  -.02(.05)  -.02(.05)  
Parameters from the joint model    
Association parameter,   .02(.001)***  .02(.001)***  
log(shape) 1.39(.02)***  1.39(.02)***  
Goodness of fit     
AIC 39,807  39,808  
BIC 39,925  39,932  
-2LL 39,765  39,764  
Note. SE = Standard error; ADL = activities of daily living; MMSE = Mini Mental State 
Examination; AIC = Akaike information criterion; BIC = Bayesian information criterion; -2LL = 
-2 × Log Likelihood. 
aAge is grand-mean centered at 64.90 years. Gender is dummy-coded (Men = -0.5, Women = 
0.5). Martial status (Married/defacto = 0.5, others = -0.5) and living arrangement (Community-
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living = 0.5, others = -0.5) are dummy-coded. Education is grand-mean centered. MMSE, 
medical conditions, and activities of daily living are within-person centered. The between-person 
mean (BP) of MMSE, medical conditions, and activities of daily living are entered in the model 
as level-2 covariates.  
bBP = Between-person mean. 
cThe JM library in R does not give the variances and covariances of random effects.  
***p < .001; **p < .01; *p < .05. 
 Figure Caption 
Figure 1. Figures 1a shows the significant gender by age interaction effect, such that the gender 
difference in depressive symptoms reduced from young-old to old-old, then reversed from the 
oldest-old. Figure 1b shows that individuals with arthritis reported a higher level of depressive 
symptoms.  
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